- Home
- NBIX vs MNDY Comparison
NBIX vs MNDY Comparison
Compare NBIX & MNDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBIX
- MNDY
- Stock Information
- Founded
- NBIX 1992
- MNDY 2012
- Country
- NBIX United States
- MNDY Israel
- Employees
- NBIX N/A
- MNDY N/A
- Industry
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- MNDY Computer Software: Prepackaged Software
- Sector
- NBIX Health Care
- MNDY Technology
- Exchange
- NBIX Nasdaq
- MNDY Nasdaq
- Market Cap
- NBIX 14.1B
- MNDY 14.6B
- IPO Year
- NBIX 1996
- MNDY 2021
- Fundamental
- Price
- NBIX $139.41
- MNDY $195.75
- Analyst Decision
- NBIX Strong Buy
- MNDY Strong Buy
- Analyst Count
- NBIX 18
- MNDY 24
- Target Price
- NBIX $161.50
- MNDY $310.17
- AVG Volume (30 Days)
- NBIX 713.3K
- MNDY 1.2M
- Earning Date
- NBIX 10-29-2025
- MNDY 11-10-2025
- Dividend Yield
- NBIX N/A
- MNDY N/A
- EPS Growth
- NBIX 2.97
- MNDY N/A
- EPS
- NBIX 3.39
- MNDY 0.76
- Revenue
- NBIX $2,509,900,000.00
- MNDY $1,100,240,000.00
- Revenue This Year
- NBIX $20.66
- MNDY $28.81
- Revenue Next Year
- NBIX $14.64
- MNDY $22.44
- P/E Ratio
- NBIX $41.44
- MNDY $254.00
- Revenue Growth
- NBIX 18.42
- MNDY 30.24
- 52 Week Low
- NBIX $84.23
- MNDY $166.22
- 52 Week High
- NBIX $154.61
- MNDY $342.64
- Technical
- Relative Strength Index (RSI)
- NBIX 53.05
- MNDY 51.12
- Support Level
- NBIX $140.56
- MNDY N/A
- Resistance Level
- NBIX $144.04
- MNDY $192.86
- Average True Range (ATR)
- NBIX 3.54
- MNDY 5.26
- MACD
- NBIX -0.26
- MNDY -2.39
- Stochastic Oscillator
- NBIX 35.85
- MNDY 99.71
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.
About MNDY monday.com Ltd.
Monday.com is a provider of work management software delivered via a cloud-based software-as-a-service, or SaaS model. The firm's solutions offer flexible and highly customizable tools to digitize business processes across countless use cases. Monday's offering supports workflow management across departments, real-time visibility and accountability, and automation capabilities. Monday also offers prepackaged CRM and DevOps management solutions, in addition to standalone survey and digital whiteboard tools. As of 2023, Monday served over 225,000 customers in more than 200 countries.